Related Business Topics
Latest Headlines
Forbes.com - Nov. 6, 2009, 11:16 AM
Nov 6 (Reuters) - Aastrom Biosciences Inc: * Reports first quarter fiscal year 2010 financial results * Q1 loss per share $0.02 * Quarterly total revenues were $73,000 * Sees cash utilization will average approximately ...
CNBC - Oct. 12, 2009, 6:53 PM
(BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/770442/tectrends_reporter) has announced the addition of the 'TecTrends Reporter: Health Care Key Recent Media Coverage, Issue 09Q2' report to their offering. Health care ...
Forbes.com - Oct. 12, 2009, 6:53 PM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/770442/tectrends_reporter) has announced the addition of the 'TecTrends Reporter: Health Care Key Recent Media Coverage, Issue 09Q2' report to their offering. Health care is ...
ABC News - Oct. 7, 2009, 4:21 PM
Aastrom Biosciences Inc., which develops stem cell therapies, said Wednesday it received a notice saying it might be subject to delisting from the Nasdaq. Aastrom Bioscience said the staff determination letter indicated the company is not in compliance ...
CNBC - Oct. 7, 2009, 1:13 PM
ANN ARBOR, Mich. - Aastrom Biosciences Inc., which develops stem cell therapies, said Wednesday it received a notice saying it might be subject to delisting from the Nasdaq. Aastrom Bioscience said the staff determination letter indicated the company is ...
A-Z Aastrom Biosciences, Inc. Provider Directory
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A

